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Abstract: In this work, we have explored 3-D co-culture of 
vasculogenic cells within a synthetically modified fibrin 
hydrogel. Fibrinogen was covalently linked with PEG-
NHS in order to improve its degradability resistance and 
physico-optical properties. We have studied influences of 
the degree of protein PEGylation and the concentration 
of enzyme thrombin used for the gel preparation on cel-
lular responses. Scanning electron microscopy analysis of 
prepared gels revealed that the degree of PEGylation and 
the concentration of thrombin strongly influenced micro-
structural characteristics of the protein hydrogel. Human 
umbilical vein endothelial cells (HUVECs) and human 
adipose-derived stem cells (hASCs), used as vasculogenic 
co-culture, could grow in 5:1 PEGylated fibrin gels prepared 
using 1:0.2 protein to thrombin ratio. This gel formulation 
supported hASCs and HUVECs spreading and the forma-
tion of cell extensions and cell-to-cell contacts. Expression 
of specific ECM proteins and vasculogenic process inherent 
cellular enzymatic activity were investigated by immuno-
fluorescent staining, gelatin zymography, western blot and 
RT-PCR analysis. After evaluation of the optimal gel com-
position and PEGylation ratio, the hydrogel was utilized for 
investigation of vascular tube formation within a perfusa-
ble microfluidic system. The morphological development of 
this co-culture within a perfused hydrogel over 12 days led 
to the formation of interconnected HUVEC-hASC network. 
The demonstrated PEGylated fibrin microfluidic approach 
can be used for incorporating other cell types, thus repre-
senting a unique experimental platform for basic vascular 
tissue engineering and drug screening applications.
Keywords: microfluidic hydrogels; PEGylated fibrin; 
tissue engineering; vasculogenesis.
Introduction
Engineering of functional blood vessels represents a major 
challenge in soft tissue reconstruction. The absence of a 
functional vasculature is the cause of numerous patholo-
gies and is also a major limiting factor in the development 
of successful tissue engineering therapies. There are two 
explicit mechanisms of blood vessel growth: vasculogen-
esis, the de novo formation of blood vessels by endothelial 
progenitor cells, and angiogenesis, the sprouting of new 
vessels from preexisting ones. For engineering of microvas-
culature within a 3-D cell laden biomaterial construct, many 
biological extracellular matrix (ECM) materials and cell 
co-cultures have been studied with respect to their vascu-
logenic potential [1–4]. Mimicking the embryonic environ-
ment for vasculogenesis is a popular strategy; for example, 
experiments on encapsulation of vascular progenitor cells 
within 3-D biological ECM have been undertaken, in which 
angioblasts and mesenchymal stem cells self-organize into 
a microvascular network and form a capillary bed [5]. The 
ability to replicate a microcapillary network formation by 
applying adult endothelial cells signifies a useful and fea-
sible option from which clinically relevant vascularized 
tissue constructs can be further developed.
To mimic native 3-D alignment of living cells in 
a living tissue, biomaterials should fulfill three main 
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objectives: ensure mass transport within the bulk of mate-
rial, exhibit an appropriate physico-chemical environ-
ment, and offer biological sites for integrin-dependent 
cell adhesion. For several decades, ECM from natural 
sources has served as an important tool for biologists. 
ECM materials include purified type I collagen, fibronec-
tin, laminin and reconstituted basement membranes (e.g. 
Matrigel®). These components of the ECM are essential 
for the establishment of proper cell growth conditions 
in a 3-D environment by providing adhesion-promoting 
compounds, as well as, by directing phenotypic cell align-
ment [6]. However, 3-D culture systems based only on pure 
ECM components exhibit certain limitations. For example, 
Matrigel® contains a population of uncharacterized and 
potentially tumor inducing growth factors, the concentra-
tion of which substantially varies among different batches 
of this biomaterial [7, 8]. Even after extracting these 
growth factors, as in purified collagen, modulation of the 
mechanical properties of collagen is impossible without 
altering its fiber network density and porosity. Finally, the 
major limitation of natural ECM systems is their relatively 
rapid in vitro degradation.
Fibrin has been qualified as an appropriate natural 
protein matrix material for vascular tissue engineering 
due to its unique properties [9]. Fibrinogen, which is the 
fibrin precursor, is a blood protein and can be autologously 
derived. The physical properties of fibrin can be controlled 
in many ways. For example, the fibrinogen concentration, 
fibrinogen to thrombin ratio, Ca2+ concentration, addition/
absence of Factor XIII, and pH conditions strongly regulate 
the network density of the fibrin gel [10]. However, fibrin 
gels undergo degradation and strong matrix remodeling 
in vitro, which results in construct shrinkage and weight 
loss [11]. PEGylation of fibrinogen is one possible method 
to control the degradation characteristics, among other 
physical properties, and to obtain new possibilities for pro-
longed 3-D vascular morphogenesis in vitro.
Synthetic and semi-synthetic hydrogels have become 
popular for engineering of soft tissues and for 3-D cell 
encapsulation due to their tunable physico-chemical 
properties and their ability to facilitate transport of 
oxygen and nutrients by diffusion. Among synthetic 
hydrogels, poly(ethylene glycol) (PEG) is a commonly 
used material for tissue engineering applications. PEG 
offers a mechanically stable, biocompatible 3-D platform 
in which living cells can be encapsulated and cultured in 
vitro or implanted in vivo [12]. Many protocols exist for the 
modification of PEGs with different chemical functional 
groups; for example, PEG can be conjugated with pep-
tides, enzymes, proteins, and other biomaterials for use 
in tissue engineering and drug delivery. Conjugation of 
ECM-like proteins with PEG can combat the issue of rapid 
in vitro degradation. PEGylation, as it is called, involves 
the reaction of hydroxyl terminal groups of a PEG molecule 
with protein amino groups to yield intra- or inter-molecu-
lar cross linking. These crosslinks modify the degradation 
properties, enhancing their stability and improving their 
therapeutic potential, particularly for tissue engineering 
applications.
Several publications have reported on entrapment of 
living cells within 3-D PEG modified fibrin matrices for 
studying cell migration, proliferation, differentiation, and 
tubulogenesis [13–16]. Zhang et  al. have reported on the 
development of a 3-D PEGylated fibrin matrix with tunable 
physical and mechanical properties [15]. The effects of 
various formulations of PEGylated fibrin environments 
on the differentiation of human mesenchymal stem cells 
(hMSCs) towards a vascular phenotype were investigated 
by analysis of angiogenic gene expression and phenotypic 
immunofluorescent staining. hMSCs formed extended 
multicellular tubes with a clear lumen only when cultured 
in fibrin matrices modified with difunctional benzoyltria-
zole carbonate (BTC)–PEG. Galler et  al. have examined 
PEGylated fibrin gel for encapsulation of different tooth-
derived stem cells as a delivery system for cell-based 
regeneration of dental structures [14]. They have demon-
strated that cells loaded into PEGylated fibrin can prolifer-
ate and produce collagen, deposit minerals, and increase 
the expression of mineralization markers after osteogenic 
induction.
In this work, we describe our studies on the applica-
tion of PEGylated fibrin gels for fabrication of a hydro-
gel-based microfluidic chamber. Human umbilical vein 
endothelial cells (HUVECs) were used as vascular precur-
sor cells and human adipose derived stem cells (hASCs) 
were used as stromal cells to support HUVEC morpho-
genesis via secretion of pro-angiogenic growth factors 
[2, 4]. It is hypothesized (a) that a cell friendly environ-
ment will support in vitro vasculogenesis that is induced 
by the interaction of HUVECs and hASCs, and (b) that 
PEGylated fibrin gel can be a strong candidate material for 
cell encapsulation and hydrogel based microfluidic device 
fabrication. Following this idea, fibrinogen was PEGylated 
in different molar ratios and used for the preparation of 
cell-laden fibrin gels by applying two different thrombin 
concentrations. The optimal gel properties for cell growth 
were first investigated via rheological analysis, scan-
ning electron microscopy (SEM) analysis of fibrilar gel 
network and observations of morphological development 
of HUVEC-hASCs co-culture. The selected formulations 
were used in the fabrication of perfusable microfluidic 
construct emulating vasculature.
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Materials and methods
Fibrinogen PEGylation
O,O′-Bis[2-(N-Succinimidyl-succinylamino)ethyl]poly(ethylene 
 glycol) (PEG-NHS), lyophilized bovine fibrinogen, and bovine throm-
bin were purchased from a commercial source (Sigma-Aldrich, 
St. Louis, MO, USA). Bovine fibrinogen was dissolved in sterile PBS at 
a 25 mg/mL protein concentration. Thrombin stock solution was pre-
pared at a 100 U/mL concentration in sterile PBS. Both solutions were 
stored at –20 °C until usage. Prior to protein PEGylation, a PEG-NHS 
solution was prepared by dissolving PEG-NHS in PBS at a 1.5 mg/mL 
concentration. PEGylation was carried out for 2 h at 37 °C by addition 
of PEG-NHS solution to fibrinogen in two different molar ratios, 10:1 
and 5:1 PEG-NHS to fibrinogen.
FT-IR analysis of PEGylated fibrinogen
FT-IR spectra were collected using a Perkin Elmer FT-IR 100 spec-
trometer. PEGylated and non-modified fibrinogen solutions were lyo-
philized prior to FT-IR sample preparation. All of the samples were 
prepared as potassium bromide (KBr) pellets, which were measured 
against pure KBr as a blank.
Characterization of fibrin and PEGylated fibrin networks 
by SEM
For the evaluation of PEGylated fibrin network architechture, the dif-
ferent gel formulations were fixed with 4% paraformaldehyde and 
dehydrated with a sequence of serially diluted ethanol (30%–100%). 
The gels were then dried using a critical point dryer and subsequently 
sputter coated with 100 nm of gold. SEM imaging was performed with 
a Quanta 400F microscope (FEI Company, OR, USA).
Rheological characterization of PEGylated fibrin gels
To study the viscoelastic properties of PEGylated and non-modified 
fibrin gels, dynamic shear oscillation experiments were carried out 
using a rheometer (Physica MCR 301, Anton Paar Germany GmbH). 
Cell-free gel samples were prepared from 1  mL of the fibrinogen 
and thrombin mixtures in a 25 mm diameter cylindrical mold and 
transferred to the bottom plate of the rheometer. The upper plate 
was then lowered to a measuring gap size of 1.7 mm. The viscoelastic 
measurements of the gels were performed using an amplitude sweep 
from 0.01% to 100% deformation. The operating temperature was 
kept constant at 22±0.1 °C. To determine the stiffness of the mate-
rials, the complex shear modulus (G*) was calculated according to 
equation (1):
 2 2(G ) (G ) (G ) ,∗ = +′ ″  (1)
where (G′) is the storage modulus and (G″) is the loss modulus. The 
results are given as average of four independently prepared gel sam-
ples from each formulation.
Cell culture
hASCs were obtained from human adipose tissue that was collected 
from patients undergoing elective plastic surgery after obtaining 
informed consent. Isolation of the cells took place according to a 
protocol described elsewhere [17]. HUVECs were purchased from 
Lonza (Basel, Switzerland). All of the cell types used in this study, 
including hASCs, were maintained in EBM-2 medium (Lonza, Basel, 
Switzerland) supplied with 1% fetal bovine serum (FBS) and 1% pen-
icillin–streptomycin and used in the experiment at passages 4–6 for 
endothelial cells and 5–7 for ASCs.
Encapsulation of cells into PEGylated fibrin
Constructs consisting of a target containing 5 × 104 cells per gel (4:1 
ratio of HUVECs to ASCs) with a 25 mg/mL fibrinogen concentration 
were formed by first diluting 20 μL of cell suspension with 30 μL of 
a PEGylated fibrinogen solution. After ensuring thorough mixing, a 
sufficient volume of thrombin stock solution to form a fibrinogen to 
thrombin ratio of either 1 mg to 1 U or 1 mg to 0.2 U was added. The 
mixture was immediately cast within a 24 well plate and cultured for 
14  days with semi-weekly media changes. The six gel formulations 
consisting of unmodified fibrinogen, 5:1 PEGylated fibrinogen, or 10:1 
PEGylated fibrinogen with either 1 U of thrombin per 1 mg protein or 
0.2 U per 1 mg were utilized for studying cellular response.
Fabrication of perfusable PEGylated fibrin microfluidic 
device
The chamber for perfused cell-laden hydrogel culture was fabri-
cated from polydimethylsiloxane (PDMS) (Sylgard 184, Dow Corn-
ing, Midland, MI, USA). The cavity for casting hydrogel, which was 
6 × 6 × 40 mm in depth, width and length, was produced by casting 
the resin around a polyoxymethylene piece. Silicone tubes ( Watson 
Marlow Limited, Falmouth Cornwall, England) with an inner diame-
ter of 0.6 mm were connected on opposite sides of the chamber using 
additional PDMS as an adhesive. An approximately 3 mm thick flat 
PDMS sheet, in which a single 6  mm hole was removed from the 
center with a coring tool, was used to enclose the chamber; the hole 
was utilized later to fill the chamber with the hydrogel mixture. The 
microfluidic channel within the hydrogel was formed by threading 
a 0.5 mm thick glass optical fiber coated with bovine gelatin, which 
was used as a release agent, through the two silicone tubes. The pre-
pared chamber was kept overnight in sterile conditions for PDMS 
solidification.
A PEGylated fibrin gel containing hASCs and HUVECs was 
prepared as follows: 300 μL of cell suspension containing 3 × 106 
HUVECs and 7.5 × 105 hASCs was distributed equally between 650 μL 
of PEGylated fibrinogen (25 mg/mL 5:1 ratio) and 650 μL of throm-
bin (10 U/mL) solutions. These cell-containing gel precursor solu-
tions were filled in two separate 2 mL syringes and connected with a 
mixing nozzle. Fixation of syringes in this manner allowed synchro-
nized injection and thorough mixing of PEGylated fibrin components 
within the chamber cavity. The injection was carried out via the 6 mm 
wide chamber opening, which afterwards was sealed with fitted 
PDMS cork and insulated with additional liquid PDMS.
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After 1 h of gelation at 37 °C, the glass optical fiber was slowly 
withdrawn from the gel via the silicone tubes, resulting in a 1 mm 
thick channel within the cell-laden PEGylated fibrin. The perfusion 
of gel construct with EBM-2 cell culture media was conducted via the 
silicone tubes using a multichannel peristaltic pump (Watson Mar-
low, Falmouth, Cornwall, UK). The gel chamber, cell culture media 
reservoir, and tubes were kept in an incubator at 37 °C in a humidified 
atmosphere containing 95% air and 5% CO2 and perfused at a 1 mL/
min flow rate.
Fluorescent cell staining
HUVECs and hASCs were labeled with Vybrant® DiO and with 
Vybrant® Dil cell tracers (Life Technologies, Darmstadt, Germany) 
according to the manufacturer’s instructions. Immunofluorescence 
staining was performed by a two-step indirect method. Briefly, the 
gels were fixed in 4% paraformaldehyde for 1 h and permeabilized 
with 1% Triton X-100/PBS. To prevent nonspecific antibody binding, 
a 2% bovine serum albumin/PBS solution was applied at 37 °C for 2 
h. After blocking, the gels were incubated with primary antibodies 
(rabbit anti PECAM/CD31 1:50, Abcam, Cambridge, UK; mouse anti 
alpha smooth muscle actin (aSMA), 1:1000, Sigma-Aldrich, Deisen-
hofen, Germany; rabbit anti MMP14,1:500, Abcam; mouse anti colla-
gen type IV, 1:50, Progen, Heidelberg, Germany; mouse anti laminin, 
1:250, Sigma-Aldrich) diluted in 1% Triton X-100/PBS overnight at 4 
°C. After several washing steps, the gels were incubated with a fluo-
rescence-conjugated secondary antibody at an appropriate dilution 
(Alexa Fluor 488 conjugated Goat anti-rabbit IgG (H+L), Dianova, 
Hamburg, Germany/Alexa Fluor® 555 conjugated Goat anti-mouse 
IgG (H+L), Life Technologies) for 1  h at 37 °C. Cell nuclei were 
stained with Hoechst 33342. Gel samples were washed three times 
and stored in PBS prior to confocal microscopy (Inverted Confocal 
LSM Zeiss 780).
Western blot analysis
Total protein was isolated from cell monolayers and gel cultures with 
ice-cold RIPA-lysis buffer (25 mM Tris-HCl (pH 7.6), 150 mM NaCl, 1% 
Nonidet P-40, 0.1% SDS, and 1% sodium deoxycholate) by sonica-
tion. The total protein concentration of the resulting lysate was 
quantified using a BCA protein assay (Roth, Karlsruhe, Germany). 
Equivalent amounts of total protein (10 μg) were loaded on a 10% 
polyacrylamide resolving gel and separated by SDS-PAGE under 
reducing conditions. After electrophoresis, proteins were transferred 
to a polyvinylidene fluoride (PVDF) membrane (Roth) by semi-dry 
blotting. The membrane was blocked for 1 h in 1 × Roti® Block (Roth) 
at room temperature. The membrane was then probed with a rab-
bit anti-human MT1-MMP antibody (MMP14 hinge region (1:1000, 
Abcam) overnight at 4 °C. After washing, the membrane was incu-
bated with a horseradish peroxidase-conjugated secondary antibody 
for 1 h at room temperature. Detection of the secondary antibody was 
performed with an enhanced chemiluminescence system using the 
Pierce ECL substrate (Thermo FisherScientific, Schwerte, Germany). 
In addition, the membrane was reprobed with a mouse anti β-actin 
antibody (1:50,000; Sigma-Aldrich) for an internal loading control. 
The relative band intensities in the scanned blots were analyzed by 
densitometry with Image J software (National Institutes of Health, 
MD, USA).
Gelatin zymography
Gelatin zymography was performed on 10% polyacrylamide gels 
copolymerized with 1 mg/mL gelatin from porcine skin (Sigma-
Aldrich). Equal amounts of protein (10 μg) were diluted in sodium 
dodecyl sulphate (SDS) sample buffer (final concentration: 50  mM 
Tris-HCl pH 6.8; 1% (w/v) SDS; 10% (v/v) glycerol; 0.025% (w/v) 
bromophenol blue) under non-reducing conditions without heat-
ing and loaded onto the gel. After electrophoresis, gels were washed 
twice for 30 min in 2.5% Triton X-100 at room temperature and incu-
bated overnight in enzyme buffer (final concentration: 50 mM Tris-
HCl, pH 7.5; 5 mM CaCl2; 100 mM NaCl; 0.1% NaN3) at 37 °C. Gels were 
stained in Coomassie Brilliant Blue R-250 (2.5 mg/mL in 10% acetic 
acid and 10% 2-propanol) for 30 min. Gels were destained in 10% ace-
tic acid and 10% 2-propanol. Gelatinolytic activity appears as clear 
bands against a blue background.
RNA extraction and RT-PCR
The total RNA was extracted from cells cultured either as a mon-
olayer or within the gels with TRIZOL® Reagent (Invitrogen, 
 Germany), which was used according to the manufacturer’s pro-
tocol. 2 μg DNAse-treated RNA was reverse transcribed to cDNA 
using MuLV reverse transcriptase (Invitrogen, Germany). Poly-
merase Chain Reaction (PCR) amplification was performed in a 
peqSTAR thermocycler (PEQLAB Biotechnologie GMBH, Erlangen, 
Germany) using gene-specific primers (Unmodified DNA oligonu-
cleotides (salt-free), Eurofins MWG Operon, Ebersberg, Germany) 
and Taq polymerase (Qiagen, Hilden, Germany). PCR cycles and 
annealing temperatures were optimized for each set of primers. 
The various cDNA samples were adjusted to equal input concen-
trations by the expression level of glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH). The following sequences were used: 
forward primer GCTTGCAAGTAACAGGCAAA and reverse primer 
AAATTCTCCGTGTCCATCCA for MT1-MMP (NM_004995.3), for-
ward primer GCATCCAGACTTCCTCAGGC and reverse primer AGG-
TATTGCACTGCCAACTC for MMP-2 (NM_004530.4), forward primer 
CGCAGACATCGTCATCCAGT and reverse primer GGATTGGCCTTG-
GAAGATGA for MMP-9 (NM_004994.2), forward primer TAAATAC-
CTGTTGCTGGGCCG and reverse primer TCCAGAACTCGTCTTCGTCG 
for MMP-19 (NM_002429.5), forward primer CGTAAAGCTATTCGC-
CGTGC and reverse primer AACCACTGGTCCTTGAAAACA for 
MT3-MMP (NM_005941.4), and forward primer CTGCACCACCAACT-
GCTT and reverse primer AGCTCAGGGATGACCTTGC for GAPDH 
(NM_001289746.1). The amplified fragments were 440 bp for MMP-2, 
589 bp for MT1- MMP, 406 bp for MMP-9, 650 bp for MT3-MMP, 302 
bp for MMP-19, and 219 bp for GAPDH. Amplified PCR products were 
separated by electrophoresis on FlashGel® DNA Cassettes (Lonza, 
Basel, Switzerland), photographed with the FlashGel® Camera, 
and documented by FlashGel® capture software (FlashGel System, 
Lonza, Basel, Switzerland).
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Results
FT-IR analysis of fibrinogen PEGylation.
The PEGylation via NHS-functionalized PEG (PEG-NHS) 
was verified via FT-IR measurements of the lyophilized 
gels [18]. Figure 1A shows the corresponding FT-IR spectra 
of pure fibrinogen, NHS-functionalized PEG, and the gels 
modified with 5:1 and 10:1 molar ratios of PEG to fibrino-
gen. The PEG-NHS shows a characteristic triplet band of 
the succinimidyl ester (1739, 1782, and 1813 cm−1), which is 
not present in the modified gels due to imide ring-opening 
within the reaction with primary amino groups [19, 20]. 
The modified gels show an increasing band at 1103 cm−1, 
indicating the insertion of PEG-derived (C-O) units 
depending on the amount of added NHS-activated PEG. 
Similar increases were observed for amide I and amide II 
bands at 1650 and 1532 cm−1 due to the amides present in 
PEG-NHS. The growth of the characteristic succinimidyl 
ester peaks and the increasing amide content are indica-
tive of successful modification of fibrinogen.
Rheological characterization of PEGylated 
fibrin gels
Storage and loss moduli were determined for 5:1 and 10:1 
molar ratios of PEGylated fibrin, as well as, for non-mod-
ified fibrin gels using a parallel plate rheometer. Complex 
shear moduli (G*), which represent the materials’ stiffness, 
were calculated according to the equation (1) (Figure 1B). 
The 5:1 PEGylation ratio increased the material stiffness 
by 30% in comparison to non-modified fibrin (161 vs. 
112 Pa). However, an increase in the PEG content in the 
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Figure 1: Characterization of PEGylated fibrin vs. non-modified fibrin. 
(A) FT-IR spectra of pure fibrinogen, NHS-functionalized PEG (PEG-NHS) and PEGylated fibrinogen with given molar ratios of PEG-NHS to 
fibrinogen; (B) Complex shear moduli of fibrin hydrogels with various molar ratios of PEG to fibrin and thrombin units (U) used for gel 
crosslinking, given as absolute values. *indicates significant difference of p < 0.5; (C) SEM analysis of PEGylated vs. non-modified fibrin. 
Scale bars are 1 μm long; and (D) Encapsulation of HUVECs (green) and hASCs (red) into PEGylated fibrin. The cells were labeled with DiO 
and DiL cell trackers before encapsulation and maintained within gels for 7 days. The scale bars are 100 μm long.
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hydrogel composition up to 10:1 ratio did not significantly 
boost its stiffness. The G* moduli of 10:1 PEGylated fibrin 
were comparable with those of 5:1 PEGylated gels (157 vs. 
161 Pa). A slight stiffness difference was observed between 
the gels prepared using 1 and 0.2 units of thrombin per 
mg of fibrinogen. The hydrogels prepared using the lower 
0.2 U thrombin concentration had overall 3%–11% lower 
complex shear moduli values in comparison to gels pre-
pared using 1 U thrombin. The PEGylated fibrin hydrogels 
were observed to be less elastic in comparison to fibrin 
gels prepared from non-modified fibrinogen and throm-
bin. The dependence of PEGylation ratio on the stiffness 
is shown by statistically significant differences (p < 0.05) 
among the PEGylated groups and non-modified fibrin.
SEM of PEGylated fibrin
SEM revealed distinct differences in fiber morphology 
among various PEGylated fibrin gels. In comparison to the 
non-modified fibrin matrix (Figure 1C), the structure of all 
of the PEGylated hydrogels appears to be strongly modi-
fied by the addition of PEG-NHS. The degree of PEGyla-
tion as well as the concentration of thrombin used for 
gel preparation also influenced the density of the protein 
hydrogel. Gels prepared from 10:1 PEGylated fibrinogen 
and both thrombin concentrations exhibited very densely 
packed fiber architectures without pores. 5:1 PEGylation 
resulted in more flocculent network alignment, with non-
uniform pore distribution and pore sizes. The 5:1 PEGylated 
fibrin gel prepared with less concentrated thrombin (1 mg; 
0.2 U ratio) exhibited a more microporous structure and 
an internal fibrillar network (see Figure  2 middle right 
image). These results of SEM analysis correlate with our 
observations of cell behavior, in which growth of HUVECs 
and hASCs was inhibited by highly modified fibrin gels 
and increased thrombin concentrations.
Morphological analysis of HUVECs and 
hASCs cultured within PEGylated fibrin gels
To evaluate how differently prepared PEGylated fibrin 
gels influence cell behavior in vitro, hASCs and HUVECs 
were embedded into PEGylated fibrin gels, followed by 
cell behavior analysis after 7 days of culture (Figure 1D). 
The gels with increased stiffness, prepared from 10:1 
PEGylated fibrinogen with thrombin concentrations of 1:1 
Figure 2: Expression of cellular and ECM proteins in hASC and HUVEC monocultures and HUVEC-hASC co-cultures within 3-D PEGylated 
fibrin gels.
Scale bars = 100 μm.
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and 1:0.2, did not support 3-D cell spreading. hASCs and 
HUVECs cultured within 10:1 PEGylated fibrin gels did not 
adequately spread within the gel, revealing rounded mor-
phologies and an absence of outgrowth. 3-D gels prepared 
from 5:1 PEGylated fibrinogen and a 1:1 ratio of protein to 
thrombin could only partially support spreading and out-
growth of hASCs but not of endothelial cells. In contrast, 
5:1 PEGylated fibrin gels with lower stiffness, which were 
prepared using a 1:0.2 protein to thrombin ratio, supported 
hASC and HUVEC growth and spreading, with the forma-
tion of cell extensions and cell-to-cell contacts (Figure 1D 
lower left image; yellow color indicates co-localization of 
hASCs and HUVECs). Therefore, 5:1 PEGylation ratio and 
0.2 U thrombin ratio were chosen for further cell encapsu-
lation experiments.
HUVECs and hASCs express various MMPs 
and MT-MMPs when cultured in PEGylated 
fibrin gels
The influence of PEGylated fibrin on the expression of 
matrix metalloproteinases (MMP) in HUVEC-hASC vascu-
logenic co-culture was compared to non-modified fibrin 
and to a traditional 2-D culture in terms of its enzymatic 
activity. Endothelial cells have been described to produce 
several MMP such as MMP-2, MMP-9, and MMP-19 as 
well as the membrane-type matrix metalloproteinases 
MT1-MMP and MP3-MMP; these molecules are impli-
cated in regulation of angiogenesis [21, 22]. The protease 
membrane type-1 matrix metalloproteinase (MT1-MMP) is 
involved in the development of endothelial cell sprouts 
and is required for capillary formation. According to 
the results of MT1-MMP immunocytochemistry, the cel-
lular expression of MT1-MMP in solo cultures of hASCs 
and HUVECs in PEGylated fibrin was much lower than 
the expression in co-culture; the strongest fluorescence 
signal in Figure  3A occurred in the gel containing both 
cell types. Western blot analysis of MT1-MMP indicated 
that its activity after 4  h post-seeding was enhanced 
in both PEGylated and non-modified 3-D gels as com-
pared to 2-D culture (Figure 3B). MT1-MMP activity in 3-D 
PEGylated fibrin gels was markedly increased starting 
from day 6 (bands 8,9,11,12) and was comparable to the 
activity in non-modified fibrin.
As demonstrated by gelatin zymography (Figure 4A), 
pro-MMP-2 was found to be active within 2-D culture, 3-D 
non-modified, and PEGylated fibrin gels from the begin-
ning of the culture. Considerable expression of the active 
form of MMP-2 was detected on day 6. It must be noted that 
the lytic activity of both latent and active forms of MMP-2 
was significantly stronger for cells cultured within 3-D 
gels compared to those in 2-D culture.
To study the MMPs that are expressed by HUVECs-
hASCs cultured in 3-D PEGylated fibrin, RT-PCR was used 
to assess the expression and regulation of MMP on a 
genetic level. Figure 4B shows that cells expressed con-
siderable amounts of MMP-2, MT1-MMP, and MT3-MMP 
mRNAs in both 2-D and 3-D culture conditions. Com-
pared to the data obtained from the gels 4 h after seeding, 
MT1-MMP was constantly upregulated over the period of 
21 days for all of the culture conditions. The upregulation 
1 2 3
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MT1-MMP 66 kDa
42 kDaβ-actin
12 days6 days3 days4 h
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Figure 3: Expression of MT1-MMP within PEGylated fibrin gel.
(A) MT1-MMP immunofluorescent staining of hASC and HUVEC monocultures as well as hASC-HUVEC co-cultures within 3-D PEGylated fibrin 
gels; MT1-MMP is green, cell nuclei are blue (scale bars = 130 μm); and (B) Western blot analysis of hASC-HUVEC MT1-MMP activity in 2-D 
(bands 1,4,7,10), 3-D PEGylated (bands 2,5,8,11), and 3-D non-modified fibrin gels (bands 3,6,9,12).
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of MT3-MMP genes was observed starting from day 3. In 
contrast to the activity of the HUVEC-hASC culture under 
2-D conditions and in non-modified fibrin gels, upregu-
lation of MT3-MMP continued over 21 days. MMP-9 and 
MMP-19 genes were also upregulated starting from day 3; 
unlike gelatinase MMP-2, these MMPs genes were down-
regulated to day 21 in both PEGylated and non-modified 
fibrin 3-D cell co-cultures.
Cellular and ECM protein expression in 
HUVEC-hASC co-culture within PEGylated 
fibrin gels
No significant expression of collagen IV was detected in 
hASC monoculture within PEGylated fibrin; however, col-
lagen IV expression was present at a low level in HUVEC 
monoculture. Expression of this protein by HUVECs 
was significantly increased in co-cultures, especially in 
regions of HUVEC and hASC contact (Figure 2A). Culture 
of hASCs alone in PEGylated fibrin gels resulted in rela-
tively low expression of αSMA, with a non-filamentous 
diffuse distribution (Figure 2B middle). However, co-
culture of hASCs with HUVECs resulted in a significant 
increase in αSMA expression and its organization into 
fibers in hASCs in direct contact with or in close prox-
imity to HUVECs (Figure 2B right). Laminin was present 
throughout the co-cultures; its highest accumulation was 
also observed to follow the geometry of HUVECs (Figure 
2B right).
Fabrication of hydrogel microfluidic chamber
Since hydrogels are porous and mechanically weak in 
general, they cannot withstand the application of high 
pressure. Therefore, the main concern in creation of a 
hydrogel-based perfusable system is a proper mechanical 
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Figure 4: Comparative molecular biological demonstration of cellular MMPs activity at different time points of culture.
(A) zymographic analysis of MMP-2; lytic bands at 72 kDa correspond to latent form of MMP-2 and bands at 62 kDa represent activated form of 
enzyme; and (B) RT-PCR analysis of HUVEC-hASC MMPs activity in PEGylated fibrin compared with 2-D co-culture and culture in non-modified 
fibrin.
Bereitgestellt von | provisional account
Angemeldet
Heruntergeladen am | 12.04.18 09:55
Koroleva et al.: Hydrogel-based microfluidics for vascular tissue engineering      27
support of the hydrogel construct. In order to achieve the 
flow of fluid (media) through the created channel without 
any leakage, a sealed bioreactor that completely encases 
the construct in a silicone material was designed. Proper 
sealing of the bioreactor seams eliminated alternative 
pathways for fluid flow and constrained the media to the 
intended path through the fabricated channel. The casting 
of gel within the chamber was performed by simultane-
ously injecting the precursor compounds through a mixing 
nozzle. The efficient mixing of PEGylated fibrin, thrombin, 
and cell suspension supported consistent distribution of 
cells within the chamber volume. Cross-linking of fibrin 
took place within minutes, which additionally prevented 
settling of the cells by gravity and therefore contributed to 
the homogeneous 3-D arrangement of HUVECs and hASCs 
within the chamber. Chamber perfusion was performed 
1  h after casting. The size of the chamber (6 × 6 × 40  mm 
W × D × L) was chosen according to our previous perfu-
sion experiments, in which the area supplied with fresh 
media by a 1 mm wide channel was established to be of 
the order of 5 mm. Figure  5A shows a cross-section of a 
12 × 12 × 40  mm large construct with a 5  mm middle core 
supplied by media.
Vasculogenesis in PEGylated fibrin microflu-
idic device
Initial observations showed that cellular responses were 
related to the ratio of fibrinogen PEGylation and the con-
centration of thrombin used for cross-linking of the gel. 
PEGylated fibrin gels with high stiffness affected cell 
growth and formation of cellular extensions. Gels with 
lower stiffness gave rise to cell spreading and establish-
ment of cell to cell contacts and interconnections. For 
the fabrication of a hydrogel perfusable chamber, a 5:1 
PEGylated fibrin cross-linked with a 1:0.2 fibrinogen to 
thrombin ratio was chosen. The hydrogel chambers were 
continuously perfused for 12 days.
Cellular outgrowths and tubular structure lengths 
were not affected by the PEGylated fibrin environment. 
The average length of cellular outgrowths and tubular 
structures in PEGylated fibrin are comparable with those 
of natural fibrin at days 3, 6 and 12 (Figure 6a).
A day after cell encapsulation, HUVECs and ASCs 
displayed rounded morphologies. hASCs spreading was 
observed to start at day two, whereas HUVECs remained 
rounded at this time (Figure 6b). Further culture resulted 
Figure 5: Silicone chamber for insulated hydrogel microfluidics.
(A) Cross section of 12 × 12 × 40 mm construct; white dotted circles indicate the 5 mm middle core supplied by media; (B) silicone chamber of 
reduced 6 × 6 × 40 mm size filled with a PEGylated hydrogel containing a co-culture of HUVECs and hASCs after 10 days of perfusion culture; 
and (C) silicone chamber connected to media reservoir via tubes.
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in the formation of longer cellular outgrowths and the 
establishment of cell-to-cell contacts between HUVECs 
and hASCs (Figure  6c). It was concluded that tubular 
3-D network formation by HUVECs was dependent on 
the co-culture with hASCs, since HUVECs encapsulated 
in PEGylated fibrin alone failed to establish intercon-
nected tubular networks. It was noted that hASCs can 
better withstand the dense PEGylated fibrin microen-
vironment, penetrating the pores of the hydrogel with 
their extensions much more easily than HUVECs. These 
cellular paths initiated by hASC spreading can further 
support the outgrowth of HUVECs (Figure  6d). Confo-
cal microscopy of perfused PEGylated hydrogels after 
12 days in culture confirms that HUVEC tube formation 
is supported by hASCs (Figure  7a, b). Moreover, the 
images of the tubes show the presence of a continuous 
lumen enclosed by HUVECs, indicating the formation 
of microvascular cord within PEGylated fibrin 3D gel 
(Figure 7c, d).
Discussion
Main factors by which microenvironmental cues of syn-
thetically modified fibrin gels can impact 3-D cell func-
tions were investigated in this study. When cells are 
encapsulated in a 3-D ECM-like protein hydrogel, struc-
tural features such as fiber size, fiber interconnectivity, 
and gel density influence cell shape and cytoskeletal 
architecture. Mechanical forces between cells and their 
ECM surroundings provide an important set of signals 
that control cell shape and function [23]. Given the struc-
tural diversity of extracellular environment components, 
it is not surprising that cellular adhesions in 3-D are 
highly variable. A PEGylation procedure was investigated 
to control the stability of fibrin gels for long term in vitro 
culture. By proper conjugation of PEG with a polypeptide 
bone of a protein molecule, modification of the molecule 
could be obtained while the biological function (e.g. enzy-
matic activity or receptor recognition) remains intact [24].
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Figure 6: HUVEC and hASC morphological development over 12 days in perfused 5:1 PEGylated fibrin gel cross-linked with 0.2 U thrombin.
(a) average length of tubular structures at day 3, 6 and 12; (b) cell morphology within perfused gel at day 2; (c) formation of tubular out-
growths at day 6; and (d) fully interconnected tubular network formed in perfused hydrogel at day 12. The cells were labeled with DiO (green 
HUVECs) and DiL (red hASCs) cell trackers prior to the experiment. Scale bars = 100 μm long.
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PEGylation of fibrinogen with NHS-functionalized PEG 
(PEG-NHS) did not influence its ability to undergo enzy-
matic crosslinking upon reaction with thrombin. Covalent 
binding of N-succinimidyl functional groups with primary 
amine groups of fibrinogen molecules was demonstrated 
using FT-IR analysis (Figure 1). Fibrin, PEGylated in differ-
ent molar ratios, was used for encapsulation of HUVECs 
and hASCs in order to evaluate the optimal gel composi-
tions for cell growth, including the ratio of thrombin and 
fibrinogen. Based on previous scientific reports, we have 
chosen 10:1 and 5:1 PEGylation ratios for fibrinogen modi-
fication [14, 25]. In contrast to pure fibrin, PEGylated fibrin 
gels remained fully transparent upon crosslinking with 
thrombin, which represents a physico-optical benefit and 
enables deep microscopic analysis of cells cultured within 
the fibrin hydrogel.
Mechanical and microstructural properties of the 
PEGylated fibrin hydrogels were elucidated using rheolog-
ical measurements and SEM observations of the dried gel 
microarchitecture. In general, PEGylation increased the 
stiffness of the fibrin gel by approximately 30%; gels pre-
pared with the lower 0.2 U thrombin concentration exhib-
ited slightly lower G* values in comparison to hydrogels 
prepared with the 1 U thrombin concentration solutions 
(Figure 1B). It should be noted that mechanical characteri-
zations were performed on bulk hydrogels and may differ 
Figure 7: Confocal microscopy images of HUVECs and hASCs co-culture within the perfused PEGylated fibrin construct.
(a, b) green HUVECs (CD31 staining), red αSMA staining represents hASCs; (c) 3D representation of confocal image stack showing the forma-
tion of HUVECs vascular network and the presence of lumen established by HUVECs (CD31 staining); and (d) enlarged view of HUVEC formed 
tube. Scale bars a,b,c = 50 μm, d = 10 μm.
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significantly from what is recognized locally by a single 
cell [26].
The trends in hydrogel stiffness can be correlated 
with cellular behavior within PEGylated fibrin hydrogels 
and with SEM observations of matrix characteristics, con-
firming strong morphological modification of the fibril-
lar network by PEG molecules (Figure 1C, D). The fibrillar 
nature of fibrin is responsible for modulating cell adhesion 
and mechanical signaling. The nanoscale character of the 
fibrin fibers is an important feature by which 3-D culture 
can impact cell function. HUVECs and hASCs cultured in 
pure, non-modified fibrin gels could relatively quickly 
develop cell extensions and establish cell-to-cell contacts, 
while continuing to proliferate, migrating and degrading 
the fibrin matrix. The 10:1 PEGylated fibrin, however, was 
determined to be not supportive for 3-D growth of this cell 
co-culture (Figure 1A, B). It could be observed from SEM 
images that 10:1 PEGylated fibrin gels represent a very 
dense-packed bulk architecture, which seems to inhibit 
cellular spatial distribution, growth, and migration 
(Figure 1C). In a fibrin gel, PEGylated at 5:1 ratio, HUVECs 
and hASCs were minimally spread when entrapped into 
gels prepared using 1 U thrombin. A further decrease in 
the enzyme concentration resulted in gels with lower stiff-
nesses, which were able to support 3-D growth of both cell 
types (Figure 1D).
Fibrin is one of the barriers that angiogenic endothe-
lial cells must penetrate during new blood vessel forma-
tion. Invasion and tubulogenesis only takes place if a 
full-length membrane-associated form of type-1 matrix 
metalloproteinase (MT1-MMP) is expressed [27]. Recently 
published analyses revealed a combinatorial MT1-MMP 
proteolytic program that governs endothelial cell chemo-
taxis, motility, and adhesion, which ultimately leads to 
angiogenesis [28]. The potent pericellular fibrinolysin 
MT1-MMP enables, otherwise surface-dwelling, endothe-
lial cells to penetrate fibrin gels and form tubular struc-
tures. In this study, the upregulation of MT1-MMP was 
noted only in hASC- HUVEC co-cultures, but not in 
HUVECs and hASCs cultured alone in PEGylated fibrin 
gels (Figure 3A). These observations additionally prove 
the dependence of the endothelial cell-mediated vasculo-
genesis process on co-culture with stromal cells (hASCs). 
Other endothelial cell MMPs are required for neovascu-
larization of fibrin to occur in vitro and in vivo. MT3-MMP 
is also involved in the regulation of tube formation by 
endothelial cells [29]. RT-PCR analysis of MT1-MMP and 
MT3-MMP genes confirms their upregulation in HUVECs-
hASCs co-cultured in 3-D PEGylated fibrin gels. MMP-2, 
MMP-9 and MMP-19 have been reported to be impli-
cated in angiogenesis [21, 30, 31]. RT-PCR analysis of 
their upregulation and downregulation revealed that 
only gelatinase MMP-2 was constantly active, whereas 
MMP-9 and MMP-19 genes were active in the first days of 
perfused culture, but silenced at day 12, when tubular 
network was formed (Figure 4B). Since MT1-MMP prote-
olyzes the pro-MMP-2 to its active form that can activate 
MMP-9, these three MMPs would form a collaborative 
network to drive the vasculogenic response [27]. The data 
presented here shows that PEGylated fibrin matrix sup-
ports the vasculogenic proteolytic program of HUVEC-
hASC co-culture.
It has been previously demonstrated that co-cultures 
of hASCs and ECs in 2-D and on Matrigel® in a ratio of 1:3 
and 1:7 (ASCs:ECs) produced a stable vascular network 
with inner layers formed by ECs and outer layers formed 
by ASCs. This phenomenon was associated with an 
increased expression of ECM proteins such as laminin, 
collagen IV, as well as cellular αSMA [2, 4]. In our study, 
we applied a 1:4 co-culture ratio of hASCs to HUVECs for 
encapsulation into PEGylated fibrin hydrogel constructs 
and confirmed that the considerable expression of col-
lagen IV, laminin and αSMA is dependent on co-culture 
of hASCs and HUVECs within the PEGylated fibrin gel 
(Figure 2). Analysis of co-localization of HUVECs (stained 
for CD31) with hASCs (stained for αSMA) at day 12 indi-
cated that hASCs were localized in the vicinity of HUVEC 
tubes (Figure 7).
Several studies reported on the formation of micro-
vascular channels by seeding endothelial cells into chan-
nels formed within a collagen I gel [32, 33]. There are a 
number of studies that utilized fibrin gel for the crea-
tion of micro vessel tubes [34–36]. The proof of principle 
described in this work utilized a similar approach for the 
formation of a single fluidic channel within the cell laden 
PEGylated fibrin gel. Here we first focused on the evalua-
tion of optimum gel properties for induction of a cellular 
lumenalized network by co-culture of vasculogenic cells. 
However, the principle of a sacrificial material intercon-
nected capillary network formation based on utilization 
of gelatin [37] or sugar [35] is certainly applicable to the 
approach described in this paper. Using a combination of 
photolithography and soft lithography methods, it should 
be possible to fabricate complex interconnected micro-
channel networks from a sacrificial material and apply 
it for embedding within cell laden PEGylated fibrin gels. 
By liquefying and flushing away the sacrificial material, 
the resulting branched micro-channels can represent 
a capillary network for conducting vasculogenic perfu-
sion studies. Subsequent seeding of these channels with 
endothelial cells will further increase the similarity of the 
channel with living tissue. This approach represents a 
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versatile tool for investigation of vasculogenesis, anasto-
mosis, and other basic and applied topics related to vas-
cular biology, including drug testing and cancer research. 
Using this approach, perfusable 3-D microfluidic capillary 
networks with various dimensions can be formed within 
the cell-containing hydrogel in vitro. Using a multichan-
nel peristaltic pump, hydrogel perfusion experiments 
could be performed in a parallel manner, examining up 
to 6 devices at the same time. Due to the relative optical 
transparency of PEGylated fibrin gels and utilization of 
transparent PDMS as microfluidic chamber, this approach 
is compatible with live-cell microscopy for monitoring of 
cellular response.
Conclusions
This proof of principle study demonstrates the use of 
hydrogel-based microfluidic system for investigations of 
vasculogenesis within perfused synthetically-modified 
fibrin gels. Mechanical properties of PEGylated hydrogel 
compositions were evaluated by rheological measure-
ments and compared with rheological characteristics of 
pure fibrin gel. The optimal hydrogel compositions con-
sidering the degree of synthetic modification and throm-
bin content, as well as, optimal cellular density and 
co-culture ratio of HUVECs and hASCs have been evalu-
ated by investigations of the morphological development 
of cells within the 3-D culture with fluorescence micros-
copy. It has been demonstrated that cells cultured within 
PEGylated gel do not lose their protheolithic program and 
express certain variety of MMPs, which are responsible 
for the formation of tubular network. Upon further evalu-
ation of appropriate mechanical and chemical microen-
vironmental qualities, the PEGylated fibrin microfluidic 
approach can be used for incorporating other cell types 
of interest, thus representing a unique experimental plat-
form for tissue engineering.
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